Evidence map›Paper›PMID 37479500›Full record

ArticleBMJ global health2023

The inclusion of diagnostics in national health insurance schemes in Cambodia, India, Indonesia, Nepal, Pakistan, Philippines and Viet Nam.

Jacob Bigio, Emma Hannay, Madhukar Pai, Bachti Alisjahbana, Rishav Das, Huy Ba Huynh, Uzma Khan, Lalaine Mortera, Thu Anh Nguyen, Muhammad Aamir Safdar and 5 more

Abstract read
In one paragraph

Article in BMJ global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jacob BigioResearch Institute of the McGill University Health Centre, Montréal, Quebec, Canada.
Emma HannayFIND, Geneva, Switzerland.ORCID 0000-0003-0464-3882
Madhukar PaiDepartment of Epidemiology & Biostats, McGill University, Montréal, Quebec, Canada.ORCID 0000-0003-3667-4536
Bachti AlisjahbanaResearch Center for Care and Control of Infectious Diseases (RC3ID), Universitas Padjadjaran, Bandung, Jawa Barat, Indonesia.
Rishav DasResearch Institute of the McGill University Health Centre, Montréal, Quebec, Canada.
Huy Ba HuynhFriends for International TB Relief, Ho Chi Minh City, Vietnam.
Uzma KhanInteractive Research & Development, Singapore.
Lalaine MorteraFamily Health International (FHI360), Manila, Philippines.
Thu Anh NguyenWoolcock Institute of Medical Research, Hanoi, Viet Nam.ORCID 0000-0002-2089-2902
Muhammad Aamir SafdarWorld Health Organization, Lahore, Pakistan.
Suvesh ShresthaSchool of Epidemiology and Public Health, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.
A Venkat RamanFaculty of Management Studies, University of Delhi, New Delhi, India.
Sharat Chandra VermaLEADERS Nepal, Kathmandu, Nepal.
Vijayashree YellappaTB PPM Learning Network, Institute of Public Health, Bengaluru, India.ORCID 0000-0003-0390-7874
Divya SrivastavaDepartment of Health Policy, London School of Economics and Political Science, London, UK d.srivastava@lse.ac.uk.ORCID 0000-0001-5135-3592

Funding

World Health Organization 001
6 · The paper itself

Abstract

The Lancet Commission on Diagnostics highlighted a huge gap in access to diagnostic testing even for basic tests, particularly at the primary care level, and emphasised the need for countries to include diagnostics as part of their universal health coverage benefits packages. Despite the poor state of diagnostic-related services in low-income and middle-income countries (LMICs), little is known about the extent to which diagnostics are included in the health benefit packages. We conducted an analysis of seven Asian LMICs-Cambodia, India, Indonesia, Nepal, Pakistan, Philippines, Viet Nam-to understand this issue. We conducted a targeted review of relevant literature and applied a health financing framework to analyse the benefit packages available in each government-sponsored scheme. We found considerable heterogeneity in country approaches to diagnostics. Of the seven countries, only India has developed a national essential diagnostics list. No country presented a clear policy rationale on the inclusion of diagnostics in their scheme and the level of detail on the specific diagnostics which are covered under the schemes was also generally lacking. Government-sponsored insurance expansion in the eligible populations has reduced the out-of-pocket health payment burden in many of the countries but overall, there is a lack of access, availability and affordability for diagnostic-related services.

Indexed as

National Health ProgramsCambodiaHumansIndiaIndonesiaNepalPakistanPhilippinesVietnamdiagnostics and toolshealth insurancehealth policy

Identifiers

PMID37479500
PMCPMC10364157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.